Obermatt
See Similar Stocks →

Drugs Made In America Acquisition II

NMQ:DMII · KYG2851K1040
Capital MarketsX-Small

360° View

no current rank
Price/Sales—
Price/Earnings16
Price/Book49
Dividend Yield1
Revenue Growth—
Profit Growth—
Capital Growth9
TSR 52w33
Leverage33
Liquidity—
Refinancing40
Combined—
Analyst Opinions—
Pro Holdings76
Opinion Changes—
Market Pulse1

Profile

CountryUSA
IndustryCapital Markets
SizeX-Small
TypePublic Company
ExchangeNASDAQGM
Founded2024
ISINKYG2851K1040
Last UpdateApr 2, 2026

Description

Drugs Made In America Acquisition II Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company intend to fo…

Similar Stocks

The companies this stock is ranked against.

Compare Drugs Made In America Acquisition II with its peers
Spark I Acquisition
NMQ:SPKL
—
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Cantor Equity Partners V
NMQ:CEPV
—
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Archimedes Tech SPAC Partners
NMQ:ATII
—
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Starry Sea Acquisition
NAQ:SSEA
—
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Pelican Acquisition
NMQ:PELI
—
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Pantages Capital Acquisition
NMQ:PGAC
—
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →